BBA

Baker Bros. Advisors Portfolio holdings

AUM $13.8B
1-Year Est. Return 85.12%
This Quarter Est. Return
1 Year Est. Return
+85.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$22.7B
AUM Growth
+$6.43B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
124
New
Increased
Reduced
Closed

Top Buys

1
+$134M
2
+$93M
3
+$83.3M
4
ADCT icon
ADC Therapeutics
ADCT
+$79M
5
ADAP
Adaptimmune Therapeutics
ADAP
+$29.9M

Top Sells

1
+$474M
2
+$101M
3
+$51.6M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$40.7M
5
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$22.8M

Sector Composition

1 Healthcare 97.74%
2 Financials 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
$2.06M 0.01%
+71,428
102
$2.04M 0.01%
97,845
103
$1.85M 0.01%
249,123
104
$1.62M 0.01%
41,928
-33,156
105
$1.03M ﹤0.01%
1,198
106
$923K ﹤0.01%
20,000
107
$525K ﹤0.01%
580,400
108
$498K ﹤0.01%
24,051
-122,969
109
$442K ﹤0.01%
172,630
110
$156K ﹤0.01%
28,396
+1,700
111
$147K ﹤0.01%
15,905
112
$128K ﹤0.01%
+5,141
113
– –
-20,000
114
– –
-126,611
115
– –
-86,066
116
– –
-4,274
117
– –
-672,912
118
– –
-8,685
119
– –
-88,026
120
– –
-20,447
121
– –
-2,093,839
122
– –
-1,638,334
1 2 3 4
5